Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2007

Conditions
Heart DiseaseNeurocognitive Decline
Interventions
DEVICE

Fresenius Cellsaver

Trial Locations (1)

M5G 2C4

Toronto General Hospital, University Health Network, Toronto

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Ontario

OTHER

lead

University Health Network, Toronto

OTHER

NCT00296985 - Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery | Biotech Hunter | Biotech Hunter